Rena J Pasick1, Galen Joseph1, Susan Stewart1, Celia Kaplan1, Robin Lee1, Judith Luce1, Sharon Davis1, Titas Marquez1, Tung Nguyen1, Claudia Guerra1. 1. Rena J. Pasick, Celia Kaplan, Tung Nguyen, and Claudia Guerra are with the Department of Medicine, Division of General Internal Medicine, University of California, San Francisco. Galen Joseph is with the Department of Anthropology, History, and Social Medicine, University of California, San Francisco. Susan Stewart is with the Division of Biostatistics, University of California, Davis. Robin Lee is with the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. Judith Luce is with the Department of Medicine, Division of Hematology and Oncology, San Francisco General Hospital, University of California, San Francisco. Sharon Davis and Titas Marquez are with the Cancer Prevention Institute of California, Fremont.
Abstract
OBJECTIVES: To determine the effectiveness of a statewide telephone service in identifying low-income women at risk for hereditary breast and ovarian cancer and referring them to free genetic counseling. METHODS:From June 2010 through August 2011, eligible callers to California's toll-free breast and cervical cancer telephone service were screened for their family histories of breast and ovarian cancer. High-risk women were identified and called for a baseline survey and randomization to an immediate offer of genetic counseling or a mailed brochure on how to obtain counseling. Clinic records were used to assess receipt of genetic counseling after 2 months. RESULTS: Among 1212 eligible callers, 709 (58.5%) agreed to answer family history questions; 102 (14%) were at high risk (25% Hispanic, 46% White, 10% Black, 16% Asian, 3% of other racial/ethnic backgrounds). Of the high-risk women offered an immediate appointment, 39% received counseling during the intervention period, as compared with 4.5% of those receiving the brochure. CONCLUSIONS: A public health approach to the rare but serious risk of hereditary breast and ovarian cancer can be successful when integrated into the efforts of existing safety net organizations.
RCT Entities:
OBJECTIVES: To determine the effectiveness of a statewide telephone service in identifying low-income women at risk for hereditary breast and ovarian cancer and referring them to free genetic counseling. METHODS: From June 2010 through August 2011, eligible callers to California's toll-free breast and cervical cancer telephone service were screened for their family histories of breast and ovarian cancer. High-risk women were identified and called for a baseline survey and randomization to an immediate offer of genetic counseling or a mailed brochure on how to obtain counseling. Clinic records were used to assess receipt of genetic counseling after 2 months. RESULTS: Among 1212 eligible callers, 709 (58.5%) agreed to answer family history questions; 102 (14%) were at high risk (25% Hispanic, 46% White, 10% Black, 16% Asian, 3% of other racial/ethnic backgrounds). Of the high-risk women offered an immediate appointment, 39% received counseling during the intervention period, as compared with 4.5% of those receiving the brochure. CONCLUSIONS: A public health approach to the rare but serious risk of hereditary breast and ovarian cancer can be successful when integrated into the efforts of existing safety net organizations.
Authors: D G R Evans; D M Eccles; N Rahman; K Young; M Bulman; E Amir; A Shenton; A Howell; F Lalloo Journal: J Med Genet Date: 2004-06 Impact factor: 6.318
Authors: Robin Lee; Mary Beattie; Beth Crawford; Julie Mak; Nicola Stewart; Miriam Komaromy; Laura Esserman; Lucille Shaw; Jane McLennan; Lori Strachowski; Judy Luce; John Ziegler Journal: Genet Test Date: 2005
Authors: Colleen M McBride; Kristi D Graves; Kimberly A Kaphingst; Caitlin G Allen; Catharine Wang; Elva Arredondo; William M P Klein Journal: Transl Behav Med Date: 2019-11-25 Impact factor: 3.046
Authors: Julia K Veitinger; Alice S Kerber; Sheryl G A Gabram-Mendola; Yuan Liu; Lynn M Durham; Diane Durrence; Alissa K Berzen; Janet Y Shin; Cindy Snyder; Cecelia A Bellcross; Yue Guan Journal: Am J Public Health Date: 2022-07-21 Impact factor: 11.561
Authors: Jennifer L Young; Julie Mak; Talia Stanley; Michelle Bass; Mildred K Cho; Holly K Tabor Journal: Genet Med Date: 2021-05-10 Impact factor: 8.822
Authors: Hiba A Moukadem; Ahmad Al Masry; Rula W Atwani; Firas Kreidieh; Lana E Khalil; Rita Saroufim; Sarah Daouk; Iman Abou Dalle; Nagi S El Saghir Journal: Eur J Breast Health Date: 2021-12-30
Authors: Megan C Roberts; Alison E Fohner; Latrice Landry; Dana Lee Olstad; Amelia K Smit; Erin Turbitt; Caitlin G Allen Journal: Genome Med Date: 2021-06-01 Impact factor: 11.117
Authors: Natalia Campacci; Juliana O de Lima; André L Carvalho; Rodrigo D Michelli; Rafael Haikel; Edmundo Mauad; Danilo V Viana; Matias E Melendez; Fabiana de L Vazquez; Cleyton Zanardo; Rui M Reis; Benedito M Rossi; Edenir I Palmero Journal: Cancer Med Date: 2017-10-21 Impact factor: 4.452